INTERCEPT-AD Study

A Phase 1 clinical trial of an investigational medication for early Alzheimer's disease (mild cognitive impairment or mild dementia due to Alzheimer’s disease).

[INTERCEPT-AD Study @Interceptstudy]

The INTERCEPT-AD study is currently seeking participants across the U.S. with memory problems that may be due to mild cognitive impairment or dementia.
If you or someone you know may be interested in participating in the study:https://t.co/d1llpV9ehp

[INTERCEPT-AD Study @Interceptstudy]

Acumen’s Chief Medical Officer, Eric Siemers MD shares about ACU193 & how it would be different from current standard of care for Alz patients.

🔗 Link to full interview: https://t.co/bEVpUX35ko

@Clinilabs
#Acumen #alzheimers #ENDALZ #alzheimersawareness

[INTERCEPT-AD Study @Interceptstudy]

AMC Research Enrolling Patients near Charlotte, NC for Clinical Trial of Promising New Investigational Treatment for Alzheimer’s Disease.

Read More:
https://t.co/MYwmwlZrM9

#alzheimers #ENDALZ #WorldAlzMonth

[INTERCEPT-AD Study @Interceptstudy]

The INTERCEPT-AD study is currently seeking participants across the U.S. with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Click to find out more:
https://t.co/SkVf4pqIMv

#alzheimers #ENDALZ

[PhillyVoice @thephillyvoice]

The study is evaluating the safety and tolerability of an investigational medication for the treatment of Alzheimer’s disease. There is no cost to participate.

Presented by @Interceptstudy https://t.co/zOJSet4xqw

[INTERCEPT-AD Study @Interceptstudy]

The INTERCEPT-AD study is currently seeking participants across the U.S. with memory problems that may be due to mild cognitive impairment or dementia.
If you or someone you know may be interested in participating in the study:https://t.co/d1llpV9ehp

[PhillyVoice @thephillyvoice]

The study is looking for volunteers to assist in evaluating the safety and tolerability of an investigational medication for the treatment of Alzheimer’s disease.

Presented by @Interceptstudy https://t.co/56d1yzQXfe

[INTERCEPT-AD Study @Interceptstudy]

Mild Alzheimer's Research Study-
Now Enrolling at sites across the U.S.

Learn more about the study: https://t.co/IxeuaKO5Br

#alzheimers #endalz

[PhillyVoice @thephillyvoice]

The study is evaluating the safety and tolerability of ACU193, an investigational medication for the treatment of Alzheimer’s disease.

Presented by @Interceptstudy https://t.co/lyknHx4z76

[INTERCEPT-AD Study @Interceptstudy]

Learn more about INTERCEPT-AD by visiting the @AcumenPharm booth at #AAIC22

[Acumen Pharmaceuticals, Inc. @AcumenPharm]

If you’re attending #AAIC22, come meet us at our booth #324 or virtually through the AAIC platform!

[Acumen Pharmaceuticals, Inc. @AcumenPharm]

In Friday's edition of @AzNewsmedia, Dr. Constantine Moschonas, MD, Medical Director at ACU193 trial site @ImagingEndpoint in Scottsdale, talks about why he is interested in exploring ACU193 & how potential participants can learn more about trial:
https://t.co/rTXvRyGAIN

[INTERCEPT-AD Study @Interceptstudy]

Experiencing memory loss?
By participating in a clinical study, you or your loved one can help to reshape Alzheimer’s treatment, helping scientists better understand how it affects the brain.
LEARN MORE: https://t.co/3qfMEbDJcn
#alzheimers #endalz

[INTERCEPT-AD Study @Interceptstudy]

Problems with memory may be a sign or mild cognitive impairment or early Alzheimer’s disease. INTERCEPT-AD is seeking people with memory symptoms to participate in a clinical research study. Learn more: https://t.co/IxeuaKx2zr
#thelongestday #endalz #alzheimers

[INTERCEPT-AD Study @Interceptstudy]

By participating in a clinical study, you or your loved one can help to reshape Alzheimer’s treatment, helping scientists better understand how it affects the brain. Learn more about the INTERCEPT-AD study.
Learn more: https://t.co/IxeuaKwuJT
#thelongestday #ENDALZ

[INTERCEPT-AD Study @Interceptstudy]

When you participate in a clinical study you provide valuable information that could eventually lead to better treatment and with the right breakthrough, better outcomes.

Learn more about the study: https://t.co/IxeuaKwuJT

#thelongestday #alzheimers #ENDALZ

[INTERCEPT-AD Study @Interceptstudy]

Alzheimer’s Study Now Enrolling
If you’ve been diagnosed with mild cognitive impairment or mild dementia due to Alzheimer’s, you may qualify for a clinical study.

Learn more: https://t.co/IxeuaKwuJT

#Alzheimers #ENDALZ #gopurple

[INTERCEPT-AD Study @Interceptstudy]

Are you or a loved one experiencing memory problems? If so, learn more about an opportunity to participate in INTERCEPT-AD, a clinical research study of a new investigational medication.

Learn more: https://t.co/SkVf4pqIMv

#alzheimers #ENDALZ #gopurple

[INTERCEPT-AD Study @Interceptstudy]

INTERCEPT-AD study has teamed up with physicians across the U.S. and sites are actively enrolling. Click to find a location near you for more information.

CLICK HERE: https://t.co/SkVf4pqIMv

[INTERCEPT-AD Study @Interceptstudy]

Experiencing memory loss? By participating in a clinical study, you or your loved one can help to reshape Alzheimer’s treatment, helping scientists better understand how it affects the brain. LEARN MORE: https://t.co/IxeuaKwuJT
#ENDALZ #AlzheimersAndBrainAwarenessMonth

[INTERCEPT-AD Study @Interceptstudy]

Are you or someone you love experiencing memory loss?

Learn more about an opportunity to participate in a clinical study: https://t.co/IxeuaKwuJT

#alzheimers #endalz #alzheimer #dementia #caregiver #caregiving #alzheimersawareness